EP4215194
COMBINATION THERAPY OF AT1 R BLOCKER AND CCR2 INHIBITOR FOR THE TREATMENT, AMELIORATION OR PREVENTION OF A KIDNEY DISEASE
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
11.1.2012EP published:
25.3.2026EP application number:
23161550.1
EPO information:
European Patent Register
Max expiry date:
10.1.2032Expiry date:
10.1.2027
Title in English:
COMBINATION THERAPY OF AT1 R BLOCKER AND CCR2 INHIBITOR FOR THE TREATMENT, AMELIORATION OR PREVENTION OF A KIDNEY DISEASELanguage of the patent:
English
Timeline
Today
11.1.2012EP application
25.3.2026EP Publication
10.1.2027Expires
Owner
Name:
Dimerix Bioscience Pty LtdAddress:
WB Block Queen Elizabeth II Medical Centre Hospital Avenue, Nedlands, Western Australia 6009, AU
Inventor
Name:
PFLEGER, Kevin Donald GeorgeAddress:
Nedlands, Western Australia, 6009, AU
Name:
MCCALL, ElizabethAddress:
Dalkeith, Western Australia, 6009, AU
Name:
WILLIAMS, JamesAddress:
Como, Western Australia, 6152, AU
Priority
Number:
2011900060Date:
11.1.2011Country:
AU
Number:
201161432896 PDate:
14.1.2011Country:
US
Number:
2011904279Date:
17.10.2011Country:
AU
Number:
201161547951 PDate:
17.10.2011Country:
US
Classification
Categories:
A61K 31/41, A61K 31/80, A61P 9/06, A61K 31/537, A61P 9/00, A61P 9/12, A61P 13/12